Prevalence of underweight, overweight, and obesity in children and adolescents with type 1 diabetes: Data from the international SWEET registry

C Maffeis, NH Birkebaek, M Konstantinova… - Pediatric …, 2018 - Wiley Online Library
C Maffeis, NH Birkebaek, M Konstantinova, A Schwandt, A Vazeou, K Casteels, S Jali…
Pediatric diabetes, 2018Wiley Online Library
Objective To assess the prevalence of underweight (UW), overweight (OW), and obesity in
children and adolescents with type 1 diabetes (T1D). Methods An international cross‐
sectional study including 23 026 T1D children (2‐18 years, duration of diabetes≥ 1 year)
participating in the SWEET prospective, multicenter diabetes registry. Body mass index SD
score (BMI‐SDS) was calculated using the World Health Organization BMI charts. Children
were categorized as UW (BMI‐SDS<− 2SD), OW (+ 1SD< BMI‐SDS≤+ 2SD), and obese …
Objective
To assess the prevalence of underweight (UW), overweight (OW), and obesity in children and adolescents with type 1 diabetes (T1D).
Methods
An international cross‐sectional study including 23 026 T1D children (2‐18 years, duration of diabetes ≥1 year) participating in the SWEET prospective, multicenter diabetes registry. Body mass index SD score (BMI‐SDS) was calculated using the World Health Organization BMI charts. Children were categorized as UW (BMI‐SDS < −2SD), OW (+1SD < BMI‐SDS ≤ +2SD), and obese (OB) (BMI‐SDS > +2SD). Hierarchic regression models were applied with adjustment for sex, age, and duration of diabetes.
Results
The prevalence of UW, OW, and obesity was: 1.4%, 22.3%, and 7.3% in males and 0.6%, 27.2%, and 6.8% in females. Adjusted BMI‐SDS was significantly higher in females than in males (mean ± SEM: 0.54 ± 0.05 vs 0.40 ± 0.05, P < 0.0001). In males, BMI‐SDS significantly decreased by age (P < 0.0001) in the first three age categories 0.61 ± 0.06 (2 to <10 years), 0.47 ± 0.06 (10 to <13 years), 0.34 ± 0.05 (13 to <16 years). In females, BMI‐SDS showed a U‐shaped distribution by age (P < 0.0001): 0.54 ± 0.04 (2 to <10 years), 0.39 ± 0.04 (10 to <13 years), 0.55 ± 0.04 (13 to <16 years). BMI‐SDS increased by diabetes duration (<2 years: 0.38 ± 0.05, 2 to <5 years: 0.44 ± 0.05, and ≥5 years: 0.50 ± 0.05, P < 0.0001). Treatment modality did not affect BMI‐SDS. Adjusted HbA1c was significantly higher in females than in males (8.20% ± 0.10% vs 8.06% ± 0.10%, P < 0.0001). In both genders, the association between HbA1c and BMI‐SDS was U‐shaped with the highest HbA1c in the UW and obesity groups.
Conclusions
The high rate of OW and obesity (31.8%) emphasize the need for developing further strategies to prevent and treat excess fat accumulation in T1D.
Wiley Online Library